Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

And while across the US, the number of STD infections has fallen annually, CDC data showed that for adolescent males aged 15 ...

The injectable, Lenacapavir, is expected to play a key role in efforts to eliminate HIV, following UNAIDS’ call for countries to end the epidemic amid funding challenges.

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...